Cooper Companies | COO - Interest Expense On Debt


Cooper Companies reported $21.5M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Abbott USD 297M 2M Sep/2026
Align Technology USD 6.93M 9.11M Mar/2026
AtriCure USD 1.21M 159K Mar/2026
Bausch Health Companies USD 402M 5M Mar/2026
Baxter International USD 78M 20M Mar/2026
Bayer EUR 675M 87M Dec/2025
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Boston Scientific USD 96M 6M Jun/2026
Cooper Companies USD 21.5M 600K Jun/2026
Dentsply International USD 22M 2M Jun/2026
Dexcom USD 3M 100K Jun/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
Haemonetics USD 5.08M 2.32M Mar/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 11M 3.7M Jun/2026
Integra LifeSciences USD 22.96M 33K Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 186M 10M Jun/2026
Merit Medical Systems USD 12.12M 5.59M Jun/2026
Novartis USD 281M 8M Sep/2025
ResMed USD 8.79M 14.55M Sep/2025
STAAR Surgical USD 800K 799K Sep/2025
Steris USD 15.8M 700K Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 27.95M 2.24M Jun/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026